xista science ventures — Full Portfolio
19 tracked investments · listed companies and verified rows first
Contextflow develops AI-powered diagnostic software for chest CT analysis that detects and tracks pulmonary nodules, quantifies lung tissue disease patterns, and retrieves similar clinical cases to support radiologists in evaluating suspected lung cancer, interstitial lung disease, and COPD.
AI & Machine LearningDigital HealthHealthtechMedical DevicesVienna, AT
Georg Langs(Chief Scientist / Co-Founder)inAllan Hanbury(Big Data Evangelist / Co-Founder)inMarkus Holzer(CEO / Co-Founder)inRené Donner(Individual ML Contributor / Technical Advisor / Co-Founder)
Co-investorsAPEX VenturesNina CapitalB&C Innovation InvestmentsCrista Galli VenturesPeak PrideNovaCapital
HEPHAISTOS is a biopharmaceutical company developing third-generation innate immune boosters (TLR4 agonists) that convert myeloid-rich, immunotherapy-resistant tumors into immunotherapy-responsive tumors.
BiotechMedical DevicesOrsay, FR
Martine Caroff(Scientific Founder)inFrederic Caroff(CEO)inFrederique Brune(CDO)inStephan Braun(CMO)inJerome Kerzerho(CSO)inChristel Lonneux(CFO and HR)in
Co-investorsElaiaAngels SantéFemmes Business Angels
AVES Reality converts real-world geographic data into simulation-ready 3D digital environments and HD maps for industrial applications.
AI & Machine LearningDeep TechDeveloper ToolsSaaSGarmisch-Partenkirchen, DE
Florian Albert(Co-founder)inSeverin Knebel(Co-founder)inMatthias Heger(Co-founder)in
Co-investorsFraunhofer Tech Transfer FundMatterwave VenturesBayern Kapital
Constructor provides AI-powered product search and discovery software for ecommerce retailers.
AI & Machine LearningE-commerceSaaSSan Francisco, US
Eli Finkelshteyn(Founder)inDan McCormick(Founder, former CTO at Shutterstock)inIgor Finkelshteyn(Executive Officer, Director)
BoardAsh Fontana(Director)in
Co-investorsFusionSapphire VenturesSilversmith Capital PartnersGreencode VenturesZetta Venture Partners
Ora Computing offers automated large language model compression using an information theory-based algorithm to shrink LLMs by up to 70% while preserving accuracy.
AI & Machine LearningCloud ComputingDeep Tech
Co-investorsGreencode Ventures
Prewave provides supply chain risk management software that helps companies monitor suppliers for sustainability and resilience risks.
AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaS
Lisa Smith(Founder)inHarald Nitschinger(Founder)in
Co-investorsaws GründungsfondsIsaiISAI GestionKOMPAS VCSeed+SpeedSpeedinvest+5 more
Ribbon Bio develops cell-free DNA synthesis and analysis products for research and diagnostics applications.
BiotechDeep Tech
Dr. Wladimir Labeikovsky(Co-Founder, Head of Data Operations)
Co-investorsHadean VenturesLansdowne Partners
Sarcura is a company with a technical team focused on semiconductors, optical development, fluidics, electronics, and systems integration, indicating work in advanced manufacturing or hardware technology.
BiotechDeep TechHardwareMedical DevicesSemiconductors
Daniela Buchmayr(CEO)
Co-investorsHCVCNovaCapitalNina Capital
VALANX Biotech develops a site-specific protein conjugation technology (GoldenSite) using click-chemistry to produce homogeneous antibody-drug conjugates with optimized conjugation sites.
AI & Machine LearningBiotech
Michael Lukesch(CEO & Founder)inGeorg Altenbacher(CBO & Co-Founder)inKlaus Orlinger(Chief Scientific Officer)in
Co-investorsSOSV
Vitrealab develops and manufactures display components for augmented reality glasses using proprietary laser waveguide technology, produced in a dedicated cleanroom with custom fabrication processes.
Deep TechHardwareSemiconductorsVienna, AT
Co-investorsAPEX Venturesaws GründungsfondsExcellis HoldingLIFTTPhotonVentures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AmplifoldFactorymakerG.ST AntiviralsInfrared CityReCatalystRivus BatteriesSolgateSyntropic Medical
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.